The news came July 21 during the insurer’s second-quarter earnings call.
Anthem joins UnitedHealth in waiting to cover the drug since its FDA approval, while a handful of Blue Cross Blue Shield affiliates have declined to cover it.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.